Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
For months, a cloud of fear has hovered over the immigrant community in San Bernardino,…
Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
For months, a cloud of fear has hovered over the immigrant community in San Bernardino, California, making it hard for María González to do her job as a community health worker in this city where almost a quarter of residents are foreign-born. It started building over the summer, fed by news of immigration raids across…
Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
HAY SPRINGS, Neb.— The sun was just warming the horizon as Mark Pieper left his house near his cattle ranch on a crisp February morning. It’s not unusual for the rancher to wake up early to tend to livestock, but at 5:45 a.m. this day his cattle wouldn’t come first. For the past 3½ years,…
Give That 1337 a Job!
By KIM BELLARD Chances are someone in your family is a gamer. Maybe you are a gamer yourself. After all, somewhere between two-thirds and three-fourths of Americans play video games, and if you just looked at young men, it’d be closer to 100%. Grumpy older people don’t get it, complaining that gaming is just a…
Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft
HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back. The post Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft appeared first on MedCity News.
Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care
Vida Health is partnering with ŌURA to use data from the Oura Ring to provide more continuous, personalized cardiometabolic care and improve patient outcomes. The post Vida Health Teams Up with ŌURA to Provide More Personalized Metabolic Care appeared first on MedCity News.
Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease
Travere Therapeutics’ Filspari is now the first FDA-approved drug for focal segmental glomerulosclerosis (FSGS), a rare kidney disease. Analysts project the pill will become a blockbuster seller. The post Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease appeared first on MedCity News.
Two visions for value – Why GCEA and HEMA clash on drug pricing
That is the title of my latest Perspectives from the Healthcare Economist article published in The Evidence Base this week. Here is the teaser: In this guest column, healthcare economist Jason Shafrin (FTI Consulting and Mann School of Pharmacy, University of Southern California) explores a widening divide over how health systems define value, and what that means…
5 of the Top 10 U.S. Health Systems Are Moving to This New Health IT Category. Here’s Why.
[Sponsored] 74% of healthcare AI is stuck in pilots. The reason isn’t the AI, it’s the data architecture underneath it. Read more to find the solution. The post 5 of the Top 10 U.S. Health Systems Are Moving to This New Health IT Category. Here’s Why. appeared first on MedCity News.
Why Synthetic Data is the Antidote to Clinical Trials
To address the clinical burden and enhance R&D, companies are turning to virtual solutions. This involves synthetic data, digital twin models, and AI to speed analysis. The post Why Synthetic Data is the Antidote to Clinical Trials appeared first on MedCity News.
Estados cambian leyes para evitar que hijos de inmigrantes detenidos entren al sistema de cuidado temporal
Mientras las autoridades migratorias llevan a cabo lo que el presidente Donald Trump ha prometido que será la mayor operación de deportación masiva en la historia de Estados Unidos, varios estados están aprobando leyes para evitar que los niños de padres detenidos, sin otros familiares o amigos, entren al sistema de cuidado temporal. El gobierno…
